Literature DB >> 17065636

Lessons from the Wiskott-Aldrich syndrome.

Jennifer M Puck1, Fabio Candotti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17065636     DOI： 10.1056/NEJMp068209

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

Review 1.  Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.

Authors:  Andre Larochelle; Cynthia E Dunbar
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

Review 2.  An update on the use of immunoglobulin for the treatment of immunodeficiency disorders.

Authors:  Stephanie Albin; Charlotte Cunningham-Rundles
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

3.  Stem-cell gene therapy for the Wiskott-Aldrich syndrome.

Authors:  Kaan Boztug; Manfred Schmidt; Adrian Schwarzer; Pinaki P Banerjee; Inés Avedillo Díez; Ricardo A Dewey; Marie Böhm; Ali Nowrouzi; Claudia R Ball; Hanno Glimm; Sonja Naundorf; Klaus Kühlcke; Rainer Blasczyk; Irina Kondratenko; László Maródi; Jordan S Orange; Christof von Kalle; Christoph Klein
Journal:  N Engl J Med       Date:  2010-11-11       Impact factor: 91.245

4.  A novel mutation in Wiskott-Aldrich gene manifesting as macrothrombocytopenia and neutropenia.

Authors:  Mais Arwani; Daniel Lee; Abdullah Haddad; Prerna Mewawalla
Journal:  BMJ Case Rep       Date:  2018-07-10

Review 5.  Rare Genetic Blood Disease Modeling in Zebrafish.

Authors:  Alberto Rissone; Shawn M Burgess
Journal:  Front Genet       Date:  2018-08-31       Impact factor: 4.599

6.  Implications of hematopoietic stem cells heterogeneity for gene therapies.

Authors:  Jeremy Epah; Richard Schäfer
Journal:  Gene Ther       Date:  2021-02-15       Impact factor: 5.250

7.  Gene therapy for Whiskott-Aldrich syndrome: The latest news.

Authors:  Marina Cavazzana; Adrian Thrasher
Journal:  Clin Transl Med       Date:  2022-04

8.  The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency.

Authors:  Lawrence R Shiow; David W Roadcap; Kenneth Paris; Susan R Watson; Irina L Grigorova; Tonya Lebet; Jinping An; Ying Xu; Craig N Jenne; Niko Föger; Ricardo U Sorensen; Christopher C Goodnow; James E Bear; Jennifer M Puck; Jason G Cyster
Journal:  Nat Immunol       Date:  2008-10-05       Impact factor: 25.606

9.  Clinical Features and Outcomes of 23 Patients with Wiskott-Aldrich Syndrome: A Single-Center Experience

Authors:  Şule Haskoloğlu; Ayşenur Öztürk; Gökcan Öztürk; Sevgi Kostel Bal; Candan İslamoğlu; Kübra Baskın; Serdar Ceylaner; Lale Tufan Satıroğlu; Figen Doğu; Aydan İkincioğulları
Journal:  Turk J Haematol       Date:  2020-08-19       Impact factor: 1.831

10.  The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decision.

Authors:  Friederike Herbst; Tonio J L Lang; Elias S P Eckert; Peer Wünsche; Alexander A Wurm; Tim Kindinger; Karin Laaber; Shayda Hemmati; Agnes Hotz-Wagenblatt; Oksana Zavidij; Anna Paruzynski; Junyan Lu; Christof von Kalle; Thorsten Zenz; Christoph Klein; Manfred Schmidt; Claudia R Ball; Hanno Glimm
Journal:  Leukemia       Date:  2021-05-21       Impact factor: 11.528
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.